CHIMERIX INC (CMRX) has 78 open-market insider trades by 22 insiders since 2013. The most active filer is Ernest Mario, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James Niedel | Dir | — | 2 | $41.4M | 2014-09-11 |
| Cantex Pharmaceuticals, Inc. | 10% Owner | — | 1 | $37.4M | 2021-09-14 |
| L. P. Canaan VII | Dir | — | 1 | $10.5M | 2014-01-21 |
| Wende S. Hutton | Dir10% | — | 1 | $10.5M | 2013-10-23 |
| New Leaf Ventures II, L.P. | 10% | — | 1 | $9.1M | 2013-10-23 |
| Farah Champsi | Dir | — | 1 | $6.9M | 2013-10-23 |
| Ernest Mario | Dir | — | 21 | $4.3M | 2018-05-18 |
| Arthur M. Pappas | Dir | — | 1 | $3.4M | 2013-10-23 |
| M. Michelle Berrey | CEOPres | — | 6 | $698K | 2018-06-12 |
| Fred A. Middleton | Dir | — | 10 | $519K | 2025-04-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Allen S. Melemed | CHIEF MEDICAL OFFICER | Sell | $14K | 2025-02-13 |
| Michael T. Andriole | President | Sell | $33K | 2025-02-13 |
| Michael Albert Alrutz | SVP AND GENERAL COUNSEL | Sell | $7K | 2025-02-13 |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Sell | $1K | 2025-02-13 |
| Michelle LaSpaluto | CFO | Sell | $10K | 2025-02-13 |
| Michelle LaSpaluto | CFO | Sell | $4K |
Companies that share insiders with CMRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-01-30 |
| Michael T. Andriole | President | Sell | $10K | 2025-01-30 |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Sell | $11K | 2025-01-30 |
| Michael T. Andriole | President | Sell | $1K | 2024-08-08 |
| Michael T. Andriole | President | Sell | $2K | 2024-02-14 |
| Michelle LaSpaluto | CFO | Sell | $2K | 2024-02-14 |
| David Jakeman | VP OF FINANCE AND ACCOUNTING | Sell | $3K | 2024-02-14 |
| Fred A. Middleton | Director | Buy | $17K | 2023-11-17 |
| Fred A. Middleton | Director | Buy | $2K | 2023-11-10 |
| David Jakeman | VP of Finance and Accounting | Sell | $4K | 2023-09-28 |